학술논문
Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial
Document Type
Article
Author
Source
In Lung Cancer March 2024 189
Subject
Language
ISSN
0169-5002